Microfluidic Nanoparticle Synthesis and Drug Delivery Systems

Microfluidic systems have emerged as a transformative platform for the controlled synthesis of nanoparticles and their integration into advanced drug delivery systems. By exploiting microscale channels and precise fluid manipulation, these technologies enable rapid mixing, tunable nucleation and growth, and real-time monitoring of particle formation. This level of control yields monodisperse populations of lipid, polymeric and inorganic nanoparticles with narrowly defined sizes, surface chemistries and encapsulation efficiencies. Continuous-flow and droplet-based microfluidic architectures facilitate high throughput fabrication while minimising reagent consumption and batch variability. Furthermore, microfluidic devices can be configured to emulate physiological environments—such as dynamic flow, concentration gradients and tissue microarchitectures—allowing in vitro screening of nanoparticle performance under conditions that closely mimic in vivo scenarios.

These platforms underpin a wide spectrum of applications, including targeted chemotherapy, nucleic acid delivery, immunomodulation and diagnostic imaging. The precise control of release kinetics, combined with modular designs that integrate multiple functionalities—such as stimuli-responsive gating, hybrid inorganic-organic matrices and real-time sensing—has accelerated translation towards clinical trials. Recent advances have also incorporated artificial intelligence and machine learning to predict and tune nanoparticle characteristics across diverse microfluidic systems. Collectively, these developments highlight the global significance of microfluidic nanoparticle synthesis as a cornerstone of next-generation drug delivery strategies.

Research from Nature Portfolio

Recent studies have shown that continuous flow-focusing in microfluidic chips allows production of polymeric nanoparticles with outstanding reproducibility and encapsulation performance. By injecting partially water-miscible solvent mixtures containing drug and poly(lactic-co-glycolic acid) into an aqueous stream, researchers have achieved precise size control and drug loading efficiencies exceeding 80%, while tuning sustained release profiles through flow rate and solvent composition adjustments. More recently, the integration of machine learning algorithms with microfluidic platforms has enabled rapid prediction and fabrication of size-tunable PLGA particles. These in silico models correlate key parameters—such as polymer concentration and phase flow rates—with particle size outcomes, offering a predictive tool for scalable manufacturing across diverse microfluidic geometries.

Microfluidic Nanoparticle Synthesis and Drug Delivery Systems publication trend

The graph below shows the total number of articles in microfluidic nanoparticle synthesis and drug delivery systems across all publications each year (not limited to Nature Index journals).

Technical terms

Microfluidics: The science of manipulating fluids in channels with dimensions of tens to hundreds of micrometres to control chemical and biological processes.

Nanoparticle: A colloidal particle with at least one dimension in the range of 1–100 nm, employed for drug encapsulation, targeting and controlled release.

Liposome: A spherical vesicle composed of lipid bilayers, used as a carrier for hydrophilic and lipophilic therapeutics in microfluidic formulation.

PLGA: Poly(lactic-co-glycolic acid), a biodegradable polymer commonly used in microfluidic synthesis of nanoparticles for controlled drug release.

Encapsulation efficiency: The percentage of an initial drug dose successfully loaded into nanoparticles during the synthesis process.

Polydispersity index (PDI): A measure of the size distribution width within a nanoparticle population, with values closer to zero indicating greater uniformity.

References

1. Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor. Scientific Reports (2017).
2. Artificial intelligence application for rapid fabrication of size-tunable PLGA microparticles in microfluidics. Scientific Reports (2020).
3. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation. ACS Nano (2023).
4. Recent Advances in Microfluidics for the Preparation of Drug and Gene Delivery Systems. Molecular Pharmaceutics (2020).
5. Nanomaterials Synthesis through Microfluidic Methods: An Updated Overview. Nanomaterials (2021).